Does BRAF V600E mutation affect recurrence rate of ameloblastomas? Systematic review and meta-analysis.
Allan Vinícius Martins-de-BarrosCaio César Gonçalves SilvaKalyne Kelly Negromonte GonçalvesRenata de Albuquerque Cavalcanti AlmeidaEmanuel Dias de Oliveira E SilvaFábio Andrey da Costa AraújoLiam RobinsonWillie F P van HeerdenMarianne de Vasconcelos CarvalhoPublished in: Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology (2023)
BRAF V600E mutation is a frequent event in ameloblastomas, but does not increase nor reduce its recurrence rate, and thus have a limited value in predicting its prognosis.